Esophageal lymphocytosis: Exploring the knowns and unknowns of this pattern of esophageal injury Review


Authors: Coady, L. C.; Sheahan, K.; Brown, I. S.; Carneiro, F.; Gill, A. J.; Kumarasinghe, P.; Kushima, R.; Lauwers, G. Y.; Pai, R. K.; Shepherd, N. A.; Slavik, T.; Srivastava, A.; Langner, C.
Review Title: Esophageal lymphocytosis: Exploring the knowns and unknowns of this pattern of esophageal injury
Abstract: Introduction: Lymphocyte-rich inflammation of the esophageal mucosa has gained increased awareness among pathologists and clinicians recently. Patients usually present with symptoms of esophageal dysfunction, including dysphagia and food bolus impaction. Endoscopy may show changes similar to eosinophilic esophagitis but may also be entirely normal (‘microscopic esophagitis’). Three morphological subtypes or variant forms have been described which include lymphocytic, lichenoid and lymphocyte-predominant esophagitis. These need to be discriminated against other distinct causes of esophageal lymphocytosis, such as gastro-esophageal reflux disease and Candida infection. Areas covered: This review provides an overview of diagnostic criteria and clinical associations of the disorder and presents an algorithmic approach to diagnosis. A comprehensive literature review was conducted using PubMed, Medline and Google Scholar databases to identify articles related to lymphocyte-rich esophageal inflammation, published up to March 2024. Expert opinion: Lymphocyte-rich inflammation needs to be included in the differential diagnosis and clinical work-up of patients with esophageal dysfunction. There is currently considerable morphological overlap among published subtypes or variant forms. Follow-up studies of affected individuals are needed to formalize diagnostic parameters and identify the clinical course of disease in order to optimize treatment modalities. © 2024 Informa UK Limited, trading as Taylor & Francis Group.
Keywords: immunohistochemistry; antibiotic agent; disease course; review; follow up; ipilimumab; diagnosis, differential; esophagitis; vomiting; differential diagnosis; pathology; risk factor; histology; dysphagia; immunology; thorax pain; systematic review; diagnosis; erythema; lichen planus; corticosteroid; gastroesophageal reflux; endoscopy; lymphocyte; lymphocytes; esophagus; deglutition disorders; candidiasis; lymphocyte count; esophagus biopsy; etiology; esophagus injury; lamina propria; lymphocytosis; esophagoscopy; eosinophilic esophagitis; nivolumab; esophagus mucosa; humans; human; igg4-related disease; drug-induced disease; immune-mediated disease; lichenoid esophagitis; lymphocyte-predominant esophagitis; lymphocytic esophagitis; esophageal mucosa
Journal Title: Expert Review of Gastroenterology and Hepatology
Volume: 18
Issue: 9
ISSN: 1747-4124
Publisher: Informa Healthcare  
Date Published: 2024-01-01
Start Page: 529
End Page: 539
Language: English
DOI: 10.1080/17474124.2024.2385493
PUBMED: 39268773
PROVIDER: scopus
DOI/URL:
Notes: Review -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors